Results

Total Results: 4,731 records

Showing results for "secondary".

2921. INTRODUCTION TO THE HCUP NATIONAL INPATIENT SAMPLE (NIS), 2019
      hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2019.jsp
      January 01, 2019 - and data elements that are not uniformly available across States, such as AHA hospital identifiers, secondary … and data elements that were not available uniformly across the States, such as hospital identifiers, secondary … procedure information ICD-10-CM diagnoses I10_DX1 - I10_DX40 ICD-10-CM diagnoses, principal and secondary … the record ICD-10-PCS procedures I10_PR1 - I10_PR25 ICD-10-PCS procedures, principal and secondary … days from admission to principal procedure PRDAY2 - PRDAY25 Number of days from admission to secondary

2922. INTRODUCTION TO THE HCUP NATIONAL INPATIENT SAMPLE (NIS), 2020
      hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2020.jsp
      January 01, 2020 - and data elements that are not uniformly available across States, such as AHA hospital identifiers, secondary … and data elements that were not available uniformly across the States, such as hospital identifiers, secondary … procedure information ICD-10-CM diagnoses I10_DX1 - I10_DX40 ICD-10-CM diagnoses, principal and secondary … the record ICD-10-PCS procedures I10_PR1 - I10_PR25 ICD-10-PCS procedures, principal and secondary … days from admission to principal procedure PRDAY2 - PRDAY25 Number of days from admission to secondary

2923. INTRODUCTION TO THE HCUP NATIONAL INPATIENT SAMPLE (NIS), 2016
      hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2016.jsp
      January 01, 2016 - and data elements that are not uniformly available across States, such as AHA hospital identifiers, secondary … and data elements that were not available uniformly across the States, such as hospital identifiers, secondary … procedure information ICD-10-CM diagnoses I10_DX1 - I10_DX30 ICD-10-CM diagnoses, principal and secondary … ICD-10-PCS procedures I10_PR1 - I10_PR15 ICD-10-PCS procedures, principal and secondary I10 … days from admission to principal procedure PRDAY2 - PRDAY15 Number of days from admission to secondary

2924. Nis 2007 Maskedstats Core Weighted (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2007_MaskedStats_Core_Weighted.PDF
      January 01, 2007 - NEOPL W OTHER O.R.PROC 6481 0.02 409: RADIOTHERAPY 4259 0.01 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … CC 109239 0.28 464: SIGNS & SYMPTOMS W/O CC 35309 0.09 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 1836 0.00 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 20076 0.05 467 … 43544 0.11 40: Multiple myeloma 18228 0.05 41: Cancer; other and unspecified primary 8458 0.02 42: Secondary … Distribution for DXCCS1 DXCCS1 Frequency Percent of Total 99: Hypertension with complications and secondary

2925. Nis 2006 Maskedstats Core Weighted (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2006_MaskedStats_Core_Weighted.PDF
      January 01, 2006 - NEOPL W OTHER O.R.PROC 5676 0.01 409: RADIOTHERAPY 4779 0.01 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … W CC 71365 0.18 464: SIGNS & SYMPTOMS W/O CC 23109 0.06 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 2454 0.01 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 23579 0.06 467 … Leukemias 39032 0.10 40: Multiple myeloma 16363 0.04 41: Cancer, other Unspecified primary 7607 0.02 42: Secondary … diseases) 89793 0.23 98: Essential hypertension 81898 0.21 99: Hypertension with complications and secondary

2926. Nis 2012 Maskedstats Core Weighted (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Core_Weighted.PDF
      January 01, 2012 - Frequency Distribution for DRG24 DRG24 Frequency Percent of Total 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … 133,005 0.36% 464: SIGNS & SYMPTOMS W/O CC 33,830 0.09% 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS 740 0.00% 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 8,715 0.02% 467 … 0.11% 40: Multiple myeloma 18,435 0.05% 41: Cancer; other and unspecified primary 7,400 0.02% 42: Secondary … Distribution for DXCCS1 DXCCS1 Frequency Percent of Total 99: Hypertension with complications and secondary

2927. HCUP National Estimates Tutorial - Accessible Version
      hcup-us.ahrq.gov/tech_assist/nationalestimates/508_course/508course_2023.jsp
      January 01, 2023 - RECNUM PRCCSR_GIS008) ; by HOSP_KID RECNUM; /* 1 is principal only, 2 is both principal and secondary … , 3 is secondary only, 0 is none */ Attrib Appendectomy length=3 label='Appendectomy (PRCCSR=GIS008 … principal procedure on the record, and a value of 2 indicates it was triggered by both the principal and a secondary … disharges should have a matching hospital record */ /* 1 is principal only, 2 is both principal and secondary … , 3 is secondary only, 0 is none */ Attrib Appendectomy length=3 label='Appendectomy (PRCCSR_GIS008

2928. Archived: Final Evidence Summary: Lipid Disorders in Children: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary34/lipid-disorders-in-children-screening-2007
      July 15, 2007 - dyslipidemias (polygenic, risk factor associated, or multi-factorial), while a minority will have monogenic or secondary … loss for overweight children, and identification and treatment of diabetes mellitus or other causes of secondary … undiagnosed monogenic dyslipidemias, such as familial hypercholesterolemia; those with undiagnosed secondary … adolescents identified by screening include those with undiagnosed monogenic dyslipidemia, undiagnosed secondary … Children and adolescents with previously known monogenic or secondary dyslipidemia would be specifically

2929. Kid 2012 Maskedstats Core Weighted (pdf file)
      hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Core_Weighted.PDF
      January 01, 2012 - NEOPL W OTHER O.R.PROC 438 0.01% 409: RADIOTHERAPY 145 0.00% 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … CC 3,012 0.05% 464: SIGNS & SYMPTOMS W/O CC 3,360 0.05% 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS <= 50 *.**% 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 1,199 0.02% … 0.11% 40: Multiple myeloma <= 50 *.**% 41: Cancer; other and unspecified primary 2,027 0.03% 42: Secondary … disease) 3,867 0.06% 98: Essential hypertension 929 0.01% 99: Hypertension with complications and secondary

2930. Kid 2012 Maskedstats Core (pdf file)
      hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2012_MaskedStats_Core.PDF
      January 01, 2012 - NEOPL W OTHER O.R.PROC 307 0.01% 409: RADIOTHERAPY 102 0.00% 410: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … CC 2,125 0.07% 464: SIGNS & SYMPTOMS W/O CC 2,384 0.07% 465: AFTERCARE W HISTORY OF MALIGNANCY AS SECONDARY … DIAGNOSIS <= 10 *.**% 466: AFTERCARE W/O HISTORY OF MALIGNANCY AS SECONDARY DIAGNOSIS 853 0.03% 467 … 0.16% 40: Multiple myeloma <= 10 *.**% 41: Cancer; other and unspecified primary 1,422 0.04% 42: Secondary … disease) 2,746 0.09% 98: Essential hypertension 650 0.02% 99: Hypertension with complications and secondary

2931. Neds 2015Q1Q3 Ip Maskedstats (pdf file)
      hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2015Q1Q3_IP_MaskedStats.PDF
      October 01, 2014 - DIAGNOSIS W MCC 56 0.00 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 165 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 14 0.00 849: RADIOTHERAPY 18 … DIAGNOSIS W MCC 56 0.00 847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 165 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 14 0.00 849: RADIOTHERAPY 18 … 3,030 0.10 40: Multiple myeloma 1,280 0.04 41: Cancer; other and unspecified primary 390 0.01 42: Secondary

2932. CERs Report cover (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-feature-treatment-future_research.pdf
      September 23, 2010 - only 210 enrolled: groups were unbalanced on mental status Primary: reoperation by 1 year; secondary … 1 year) used 5 point scale No significant differences in reoperation at 1 year or EQ-5D, any secondary … Secondary: mortality, pain, hip function and mobility No significant differences mortality at … Secondary: perioperative factors Decreased trend in early mortality in PCCp group (p=0.51).

2933. Making Healthcare Safer IV Rapid Review: Examining the Impact of Implementing High-Reliability Organization Principles on Patient Safety Outcomes (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/hro-rapid-research.pdf
      May 01, 2025 - Comparator Any No comparator Outcome Primary outcome: Any patient safety event Secondary … The two new studies did not meet eligibility criteria for this report because one reported only secondary … , Year Study Design Setting HRO Framework HRO Activities* Primary Outcome Measures Secondary … Primary study results and quality Author, Year Primary Outcomes Secondary Outcomes Quality Sculli

2934. Radiation Therapy for Brain Metastases: A Systematic Review | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/radiation-brain-metastases/protocol

2935. Glaucoma-Treatment Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_executive.pdf
      April 01, 2012 - Secondary open-angle glaucoma: Glaucoma in the setting of an eye with a visibly open anterior chamber … Examples of secondary open- angle glaucomas include pigment dispersion syndrome, pseudoexfoliation syndrome … instrument had to address the primary outcome of vision- related quality of life (primary outcome) or the secondary … • The available studies addressing the secondary outcomes of change in visual acuity and change in

2936. Infectious Disease Including HIV/AIDS #09 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
      December 01, 2013 - HS723 - Collaborative care model (HITIDES) for treatment of depression secondary to HIV. 2011 Oct … HS723 - Collaborative care model (HITIDES) for treatment of depression secondary to HIV. 2011 Oct … HS723 - Collaborative care model (HITIDES) for treatment of depression secondary to HIV. 2011 Oct … HS723 - Collaborative care model (HITIDES) for treatment of depression secondary to HIV. 2011 Oct … HS723 - Collaborative care model (HITIDES) for treatment of depression secondary to HIV. 2011 Oct

2937. Rapid-Reviews-End-User White-Paper (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-reviews-end-user_white-paper.pdf
      April 01, 2016 - alterations (e.g., single review at multiple steps of the systematic review process) appear to be secondary … decisions”; to act as an update for a previous comprehensive guideline or address an issue that comes up secondary … response products apply a best evidence approach and report the results of primary studies if no secondary

2938. AHRQ Safety Program for Improving Antibiotic Use: Final Report (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/overall-antibiotic-stewardship-project-final-report.pdf
      September 01, 2022 - Three secondary outcomes 10 were also evaluated: C. difficile laboratory-identifiable events … Secondary outcomes included days of antibiotic therapy per 1,000 resident-days, C. difficile LabID … Secondary outcomes were antibiotic prescriptions per 100 visits.

2939. Supplemental Project To Assess the Transparency of Reporting Requirements for Studies Evaluating the Effectiveness of Treatment Options for Symptoms of Diabetic Peripheral Neuropathy (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
      March 01, 2018 - Description of pre-specified primary outcomes, number of primary outcomes 3 Description of secondary … outcome Analysis Description of the pre-specified statistical analysis plan Results of primary and secondary … None of the studies changed a primary outcome to a secondary outcome. … if ever published, would be unlikely to add to the body of evidence because none of the primary or secondary … Results should consist of demographic and baseline characteristics, primary and secondary outcomes,

2940. Screening for Osteoporosis to Prevent Fractures: A Systematic Evidence Review for the USPSTF (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/R_cAa3AjFGQ2np_aQnzQGA
      February 11, 2025 - denosumab compared with pla- cebo or no treatment were eligible if most enrolled participants did not have secondary … FRAX without BMD assessment, DXA, VFA, fall risk assessment, and blood chemistry analyses to exclude secondary … in persons with a history of fragility fracture or medical conditions or medications associated with secondary … Anti-fracture efficacy of zoledronate in subgroups of osteopenic postmenopausal women: secondary analysis … Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis.